MAIA Biotechnology, Inc.
MAIA · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $10 | $11 | $9 | $3 |
| G&A Expenses | $7 | $9 | $6 | $4 |
| SG&A Expenses | $7 | $9 | $6 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Expenses | $17 | $20 | $16 | $8 |
| Operating Income | -$17 | -$20 | -$16 | -$8 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$6 | $0 | $0 | -$5 |
| Pre-Tax Income | -$23 | -$20 | -$16 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23 | -$20 | -$16 | -$13 |
| % Margin | – | – | – | – |
| EPS | -1.05 | -1.49 | -1.7 | -1.18 |
| % Growth | 29.5% | 12.4% | -44.1% | – |
| EPS Diluted | -1.05 | -1.49 | -1.7 | -1.18 |
| Weighted Avg Shares Out | 22 | 13 | 9 | 11 |
| Weighted Avg Shares Out Dil | 22 | 13 | 9 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$23 | -$20 | -$16 | -$12 |
| % Margin | – | – | – | – |